Fierce Pharma2d
Senate investigation claims Pfizer shifted profits offshore in what could be pharma's 'largest tax-dodging scheme'
The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...
Pfizer: Shares Stabilize At $25 As Institutions Begin To Load Up (Rating Upgrade)
Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...
Why Pfizer Is My Largest Healthcare Position
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
Senator Slams Pfizer (PFE) for “Biggest Tax-Dodging Scheme in Pharma History”
Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
Pfizer Is Now a High-Yield Bargain Stock
Pfizer's stock has recently struggled but remains a bargain with generous dividends. Is now a good time to invest in PFE?
Pfizer Inc. (PFE): Among Blue Chip Stocks to Invest in at 52-Week Lows
We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...
Explore more
China.org.cn9h
U.S. pharmaceutical giant opens R&D center in Beijing
BEIJING, March 30 (Xinhua) -- U.S. pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA) on ...
CMSWire4d
How Pfizer Is Building Customer Experience From the Inside Out
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with ...